Dysregulated NUB1 and Neddylation Enhances Rheumatoid Arthritis Fibroblast‐Like Synoviocyte Inflammatory Responses
Arthritis & Rheumatology · 2024-08 · 76 (8) · 1252-1262
DOI: 10.1002/art.42856 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 05.06.2024. Verfasst von Sho Sendo und 7 weiteren Autor:innen. Beteiligte Einrichtung: University of California, San Diego, School of Medicine, La Jolla. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Synoviocytes, Cyclopentanes, Fibroblasts. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAMS NIH HHS, Eli Lilly and Company.
Abstract (Originalsprache)
Objective
Fibroblast‐like synoviocytes (FLS) contribute to the pathogenesis of rheumatoid arthritis (RA), in part due to activation of the proinflammatory transcription factor NF‐κB. Neddylation is modulated by the negative regulator of ubiquitin‐like protein (NUB) 1. We determined whether NUB1 and neddylation are aberrant in the models with RA FLS, thereby contributing to their aggressive phenotype.
Methods
Models with RA or osteoarthritis (OA) FLS were obtained from arthroplasty synovia. Real‐time quantitative polymerase chain reaction and Western blot analysis assessed gene and protein expression, respectively. NUB1 was overexpressed using an expression vector. NF‐κB activation was assessed by stimulating FLS with interleukin (IL)‐1β. Neddylation inhibitor (MLN4924) and proteasome inhibitor were used in migration and gene expression assays. MLN4924 was used in the model with K/BxN serum‐transfer arthritis.
Results
Enhanced H3K27ac and H3K27me3 peaks were observed in the NUB1 promoter in the OA FLS compared with the RA FLS. NUB1 was constitutively expressed by FLS, but induction by IL‐1β was significantly greater in the OA FLS. The ratio of neddylated cullin (CUL) 1 to nonneddylated CUL1 was lower in the OA FLS than the RA FLS. NUB1 overexpression decreased NF‐κB nuclear translocation and IL‐6 messenger RNA (mRNA) in IL‐1β–stimulated the RA FLS. MLN4924 decreased CUL1 neddylation, NF‐κB nuclear translocation, and IL‐6 mRNA in IL‐1β–stimulated the RA FLS. MLN4924 significantly decreased arthritis severity in the model with K/BxN serum‐transfer arthritis.
Conclusion
CUL1 neddylation and NUB1 induction is dysregulated in the models with RA, which increases FLS activation. Inhibition of neddylation is an effective therapy in an animal model of arthritis. These data suggest that the neddylation system contributes to the pathogenesis of RA and that regulation of neddylation could be a novel therapeutic approach. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of California, San Diego, School of Medicine, La Jolla.
- Eli Lilly and Company, Indianapolis, Indiana.
- Eli Lilly and Company, Indianapolis, Indiana, and Eli Lilly and Company, San Diego, California.
- University of California, San Diego, La Jolla.
ORCID-Profile: Sho Sendo, Gary S Firestein
Förderung
- NIAMS NIH HHS
- Eli Lilly and Company
Zitieren
APA
Sendo, S., Machado, C. R. L., Boyle, D. L., Benschop, R. J., Perumal, N. B., Choi, E., Wang, W., & Firestein, G. S. (2024). Dysregulated NUB1 and Neddylation Enhances Rheumatoid Arthritis Fibroblast‐Like Synoviocyte Inflammatory Responses. Arthritis & Rheumatology, 76(8), 1252-1262. https://doi.org/10.1002/art.42856
Vancouver
Sendo S, Machado CRL, Boyle DL, Benschop RJ, Perumal NB, Choi E, et al. Dysregulated NUB1 and Neddylation Enhances Rheumatoid Arthritis Fibroblast‐Like Synoviocyte Inflammatory Responses. Arthritis & Rheumatology. 2024;76(8):1252-1262. doi:10.1002/art.42856
BibTeX
@article{Sendo2024,
author = {Sendo, Sho and Machado, Camilla R L and Boyle, David L and Benschop, Robert J and Perumal, Narayanan B and Choi, Eunice and Wang, Wei and Firestein, Gary S},
title = {Dysregulated NUB1 and Neddylation Enhances Rheumatoid Arthritis Fibroblast‐Like Synoviocyte Inflammatory Responses},
journal = {Arthritis & Rheumatology},
year = {2024},
volume = {76},
number = {8},
pages = {1252--1262},
doi = {10.1002/art.42856}
}
EUVIMED